The race to contain bird flu outbreaks in US poultry and cattle farms has led to a groundbreaking development in the form of an mRNA vaccine for cattle. Researchers have successfully tested this vaccine against avian influenza in calves, with promising results. The experimental vaccine has shown to trigger a strong immune response to the virus and effectively protect against infection in calves.
The development of this mRNA bird flu vaccine for cattle could be a significant step in reducing the risk of animal-to-human transmission of the virus, which poses a real pandemic threat. The recent findings, although not yet peer-reviewed, have been posted on the preprint server bioRxiv, showcasing the potential of this vaccine in combating bird flu outbreaks.
The urgency to find solutions to the rising threat of a bird flu pandemic has been heightened by the confirmed outbreak of the H5N1 avian influenza virus in dairy cattle in March 2024. Since then, the virus has affected over 1,000 dairy herds across 17 US states, leading to 64 human infections and one death linked to the outbreak.
The development of the mRNA vaccine for cattle builds on over a decade of work on seasonal bird flu vaccines. Researchers have successfully modified the vaccine candidate to target the H5N1 virus found on dairy farms, demonstrating the versatility and effectiveness of mRNA-based vaccines in combating emerging viral threats.
The study, which inoculated 10 calves and exposed them to H5N1-infected cows, showed that the vaccinated calves had significantly lower levels of viral RNA compared to the unvaccinated calves. While further trials in lactating cows are underway, these initial results are a promising indication of the vaccine’s efficacy in preventing avian flu transmission among cattle.
The future of livestock vaccines looks promising, with the US Department of Agriculture approving several candidates for field trials this year, including a bird flu vaccine for chickens. However, political challenges against mRNA vaccines, as well as concerns about the economic viability of cattle vaccines, may pose obstacles to widespread adoption.
Despite these challenges, the development of vaccines for cattle is seen as a necessary step in preventing further infections, potential deaths, and economic losses in the livestock industry. The need for innovative solutions to combat bird flu outbreaks is evident, and the mRNA vaccine for cattle represents a significant advancement in that direction.
